Pharmacokinetics, dose proportionality and permeability of S002-333 and its enantiomers, a potent antithrombotic agent, in rabbits-Reference-Cited by-同舟云学术

Pharmacokinetics, dose proportionality and permeability of S002-333 and its enantiomers, a potent antithrombotic agent, in rabbits

Published:2015-06-18 Issue:11 Volume:45 Page:1016-1023
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Saxena Amrita,Valicherla Guru R.,Joshi Pankaj,Saxena Rohit,Cheruvu Srikanth H.,Bhunia Shome S.,Jain Girish K.,Siddiqui Hefazat H.,Saxena Anil K.,Gayen Jiaur R.

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00498254.2015.1034224

Reference17 articles.

1. Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies

2. Bioanalytical method development and validation for simultaneous estimation of (R)- and (S)-isomers of S002-333: a potent novel anti-thrombotic agent using LC–MS/MS

3. Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity

4. Simultaneous high-performance liquid chromatographic assay of furosemide and propranolol HCL and its application in a pharmacokinetic study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of research on the impact of E171/TiO2 NPs on the digestive tract;Journal of Trace Elements in Medicine and Biology;2022-07

2. A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential;ChemMedChem;2020-10-21

3. Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin;Pharmaceutics;2018-09-12

4. Evaluation of oral pharmacokinetics, in vitro metabolism, blood partitioning and plasma protein binding of novel antidiabetic agent, S009-0629 in rats;Drug Development Research;2018-06

5. Insight into stereoselective disposition of enantiomers of a potent antithrombotic agent, S002-333 following administration of the racemic compound to mice;European Journal of Pharmaceutical Sciences;2017-04